Pharma and Biotech Daily: Elevidys setback, Lilly's big commitment, and more!

Pharma and Biotech Daily: Elevidys setback, Lilly's big commitment, and more!

Author: Pharma and BioTech News July 28, 2025 Duration: 1:13
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. The European Medicines Agency's CHMP did not recommend approving Elevidys for ambulatory patients with Duchenne muscular dystrophy, dealing a blow to Sarepta. FDA is rumored to request new data for Elevidys, leading to uncertainty as FDA considers a new study for the drug. In other news, Eli Lilly commits $856 million to Gate Bioscience for a new class of medicines, while Rocket trims headcount and pipeline focus. Roche also drops an early obesity asset as layoffs continue in the biopharma industry, with companies like Adicet optimizing their pipelines. Novartis makes a billion-dollar drug discovery deal with Matchpoint, and the FDA opens a pilot run of the commissioner voucher program.Stay tuned for more updates on the latest developments in the pharmaceutical and biotech world.

Support the show


Every morning, the world of life sciences shifts with new clinical data, strategic deals, and regulatory decisions. Keeping pace with it all is a full-time job. Pharma and BioTech Daily is designed to be that essential, efficient briefing for professionals and investors who need the signal through the noise. This daily podcast delivers a concise, human-curated audio update that synthesizes the most critical developments from the previous day. You’ll hear clear summaries of pipeline milestones, merger and acquisition activity, policy changes, and corporate strategy shifts-all contextualized for their real-world impact. The production leverages AI tools to monitor vast data streams, but each episode is carefully supervised and narrated by editors to ensure accuracy and relevance. It’s for anyone who builds companies in this space, manages portfolios, or makes strategic decisions where science meets business. Tune in for a focused, factual, and time-saving digest that fits into your morning routine, brought to you by the team at Pharma and BioTech News and produced by the boutique studio OWITH.ai. This isn't about lengthy interviews or opinion; it's a streamlined tool to inform your day in the complex, fast-moving pharma and biotech landscape.
Author: Language: English Episodes: 236

Pharma and BioTech Daily
Podcast Episodes
2025 Pharma Breakthroughs: Asthma, Cancer, and RNAi [not-audio_url] [/not-audio_url]

Duration: 5:10
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. As we close out the year 2025, it's clear that the pharmaceutical and biotech industrie…
FDA Approvals and Global Biotech Innovations [not-audio_url] [/not-audio_url]

Duration: 10:06
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of significant updates that are shaping the future of hea…
FDA Approvals Propel Oncology and Cardiovascular Innovations [not-audio_url] [/not-audio_url]

Duration: 7:19
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving deep into the latest breakthroughs, regulatory updates, and industr…
Revolutionizing Insurance for High-Cost Gene Therapies [not-audio_url] [/not-audio_url]

Duration: 6:12
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the exciting, yet challenging, landscape of gene therapies and the…
Breakthroughs and Challenges: Eli Lilly's Obesity Drug Triumphs [not-audio_url] [/not-audio_url]

Duration: 6:44
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a myriad of transformative advancements and strategic shifts withi…
Transformative Breakthroughs in Cancer and Gene Therapy [not-audio_url] [/not-audio_url]

Duration: 7:01
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. In the ever-dynamic landscape of these industries, recent advancements have underscored…
Revolutionizing Drug Development: Key Industry Breakthroughs [not-audio_url] [/not-audio_url]

Duration: 7:36
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we dive into a series of transformative events shaping the future of drug develo…
Revolutionizing Hemophilia and Epilepsy Treatments: Key Developments [not-audio_url] [/not-audio_url]

Duration: 6:11
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of compelling advancements and challenges that are shapin…
Keytruda SC Legal Battle and CAR-T Milestones [not-audio_url] [/not-audio_url]

Duration: 6:32
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we dive into a series of pivotal events shaping the landscape of drug developmen…
Navigating Regulatory Shifts and Biotech Breakthroughs [not-audio_url] [/not-audio_url]

Duration: 6:12
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, the landscape of the pharmaceutical and biotech industries is marked by groundbr…